Edition:
United States

Omeros Corp (OMER.OQ)

OMER.OQ on NASDAQ Stock Exchange Global Market

26.46USD
4:00pm EDT
Change (% chg)

$1.42 (+5.67%)
Prev Close
$25.04
Open
$24.90
Day's High
$26.56
Day's Low
$24.90
Volume
206,717
Avg. Vol
180,154
52-wk High
$26.96
52-wk Low
$8.36

Chart for

About

Omeros Corporation is a commercial-stage biopharmaceutical company. The Company is engaged in discovering, developing and commercializing small-molecule and protein therapeutics for large-market as well as orphan indications targeting inflammation, complement-mediated diseases and disorders of the central nervous system. The... (more)

Overall

Beta: 3.47
Market Cap(Mil.): $1,215.94
Shares Outstanding(Mil.): 48.56
Dividend: --
Yield (%): --

Financials

  OMER.OQ Industry Sector
P/E (TTM): -- 108.33 32.69
EPS (TTM): -1.83 -- --
ROI: -149.41 1.50 12.72
ROE: -- 0.19 14.85

BRIEF-Omeros Says Entered Into Settlement Agreement And Consent Judgment With Lupin Ltd and unit Lupin Pharmaceuticals - SEC Filing

* OMEROS SAYS ENTERED INTO SETTLEMENT AGREEMENT AND CONSENT JUDGMENT WITH LUPIN LTD, SUBSIDIARY LUPIN PHARMACEUTICALS - SEC FILING

May 24 2018

BRIEF-Omeros Corporation Q1 Loss Per Share $0.62

* Q1 EARNINGS PER SHARE VIEW $-0.62 -- THOMSON REUTERS I/B/E/S Source text for Eikon: Further company coverage:

May 10 2018

BRIEF-FDA Grants Breakthrough Therapy Designation To Omeros' Masp-2 Inhibitor Oms721

* FDA GRANTS BREAKTHROUGH THERAPY DESIGNATION TO OMEROS’ MASP-2 INHIBITOR OMS721 FOR THE TREATMENT OF HIGH-RISK HEMATOPOIETIC STEM CELL TRANSPLANT-ASSOCIATED THROMBOTIC MICROANGIOPATHY

Apr 26 2018

BRIEF-Omeros Announces Amendment Of Credit Facility

* AMENDED ITS EXISTING CREDIT FACILITY WITH CERTAIN AFFILIATES OF CRG LP

Apr 11 2018

Competitors

  Price Chg
Johnson & Johnson (JNJ.N) $140.47 -2.41
Novartis AG (NOVN.S) CHF81.80 -0.08
Pfizer Inc. (PFE.N) $43.93 -0.13
Roche Holding Ltd. (ROG.S) CHF233.00 -2.15
Roche Holding Ltd. (RO.S) CHF234.00 -1.40
Merck & Co., Inc. (MRK.N) $70.78 -0.32
Bayer AG (BAYGn.DE) €76.15 -0.37
Bayer AG (BAYE.F) -- --
Sanofi SA (SASY.PA) €73.86 -0.64
Eli Lilly And Co (LLY.N) $105.59 -0.74

Earnings vs. Estimates